Scientists use special drugs to target tumor cells

Their landmark work-just published in the leading international journal Nature Genetics and supported by the World Cancer Research and Brain Tumor Charity-will provide a new understanding of the genetics of DMG progress.

Scientists are now calling for the immediate start of clinical trials to evaluate an approved class of drugs called "EZH2 inhibitors

Adrian Bracken, a professor in the School of Genetics and Microbiology at Trinity College, led this exciting research

"Ultimately, we hope that our work — and the work of others who specialize in this field — will lead to clinical treatments for this truly terrible disease, which can destroy families, and there are currently no treatment options

Childhood gliomas like DMG are one of the most devastating childhood cancers

Dr.

Speaking of the importance of this work, Maeve Lowery, Professor of Translational Cancer Medicine at Trinity College and Academic Director of the Trinity St.

Dr.

Journal Reference :

1. Gerard L.